Canagliflozin for type 2 diabetes with mild memory problems
Treatments studied
Part of Hormones & metabolism, Mental health clinical trials.
This trial tests whether the diabetes drug canagliflozin can help people with type 2 diabetes and mild cognitive impairment. It may slow down memory and thinking problems while also improving blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old
- You have mild cognitive impairment (memory or thinking problems that are worse than normal aging but not dementia)
- Your average blood sugar (A1c) is between 7.0 and 10.0%
- You must have had type 2 diabetes for at least 6 years
- You are only taking metformin for diabetes (no other diabetes pills in the last 90 days)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study screens older adults with type 2 diabetes for early signs of memory or thinking problems, and offers a program to help keep the brain healthy. It aims to find out if a combination of lifestyle changes, mental exercises, and medical support can slow cognitive decline.
This study uses MRI scans to look at a specific brain circuit (the Papez loop) in people with type 2 diabetes. It aims to understand how diabetes might affect brain networks related to memory and emotion.
This study tests whether a diabetes drug called a DPP4 inhibitor can help protect memory and thinking after a mild stroke. It is for people with type 2 diabetes who have had a stroke within the last two weeks.
This trial tests if metformin can help older adults (60-75) who are overweight and have mild memory problems. It aims to see if the drug can slow down or improve memory issues.
This study tests a new diabetes pill called henagliflozin to see if it helps smooth out blood sugar ups and downs and may also slow aging of the immune system in people with type 2 diabetes who are already on insulin. It is for adults aged 50–70 whose blood sugar is still high despite insulin therapy.
This trial tests whether a combination of cilostazol (a blood flow medication) and ginkgo (a herbal supplement) can help protect memory and thinking skills in people over 60 with type 2 diabetes. You may join if your memory is slightly below normal but not severely impaired.
Hear when a new Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.